argenx to Highlight Key Programs from Neuromuscular
Scientific presentations demonstrate argenx’s leadership in FcRn blockade and commitment to innovating for patients across multiple neuromuscular diseases ...
Stay updated with breaking news from Scientific Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scientific presentations demonstrate argenx’s leadership in FcRn blockade and commitment to innovating for patients across multiple neuromuscular diseases ...
Go ahead and have that extra cup of coffee, it might reduce your risk of heart failure or stroke.
Kira Pharmaceuticals to Present New Preclinical Data on Lead Asset KP104 at the 2022 European Meeting on Complement in Human Disease Conference - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, will...
A physician expert at Teladoc Health digs into its recent report on social determinants and digital health, with a special focus on remote patient monitoring and diabetes.